Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors-Reference-Cited by-同舟云学术

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

Published:2010-05-05 Issue:9 Volume:102 Page:596-604
ISSN:1460-2105
Container-title:JNCI: Journal of the National Cancer Institute
language:en
Short-container-title:

Author:

Maitland Michael L.¹,Bakris George L.¹,Black Henry R.¹,Chen Helen X.¹,Durand Jean-Bernard¹,Elliott William J.¹,Ivy S. Percy¹,Leier Carl V.¹,Lindenfeld JoAnn¹,Liu Glenn¹,Remick Scot C.¹,Steingart Richard¹,Tang W. H. Wilson¹,

Affiliation:

1. Affiliations of authors: Section of Hematology/Oncology, Department of Medicine, Committee on Clinical Pharmacology and Pharmacogenomics, Comprehensive Cancer Center (MLM), and Section of Endocrinology, Department of Medicine, University of Chicago, Chicago, IL (GLB); Center for the Prevention of Cardiovascular Disease, Division of Cardiology, New York University School of Medicine, New York, NY (HRB); Investigational D

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Oncology

Link

http://academic.oup.com/jnci/article-pdf/102/9/596/17310947/djq091.pdf

Reference42 articles.

1. Reversible posterior leukoencephalopathy syndrome and bevacizumab;Glusker;N Engl J Med,2006

2. Reversible posterior leukoencephalopathy syndrome and bevacizumab;Ozcan;N Engl J Med,2006

3. Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib;Chu;Lancet,2007

4. Heart failure associated with sunitinib malate: a multitargeted receptor tyrosine kinase inhibitor;Khakoo;Cancer,2008

5. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma;Schmidinger;J Clin Oncol,2008

Cited by 372 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of blood pressure control on the risk of proteinuria during bevacizumab treatment in patients with colorectal cancer: a single-center retrospective cohort study;Journal of Pharmaceutical Health Care and Sciences;2024-08-23

2. Clinical Outcome of Colorectal Cancer Patients with Concomitant Hypertension: A Systematic Review and Meta-Analysis;Journal of Personalized Medicine;2024-05-14

3. Cardiorenal Impact of Anti-Cancer Agents: The Intersection of Onco-Nephrology and Cardio-Oncology;Cardiorenal Medicine;2024-04-29

4. Use of new and emerging cancer drugs: what the cardiologist needs to know;European Heart Journal;2024-04-09

5. Hypertension as predictive factor for bevacizumab-containing first-line therapy in metastatic breast and colorectal cancer in BRECOL (GEICAM/2011-04) study;Clinical and Translational Oncology;2024-04-05